Prevalence and factors associated with depression and anxiety among COVID-19 survivors in Dhaka city

Author:

Kibria Md. Golam1,Rahman Ummay Salma2,Islam Taslima3,Amin S M Sayadat4,Rahman Md. Mahbubur5,Ahmed Shakil6

Affiliation:

1. Department of Research, Centre for Development Action, Dhaka-1207, Bangladesh

2. Department of Research, Centre for Development Action, Dhaka-1207, Bangladesh; Upstream Lab, St. Michael's Hospital, 36 Queen St E, Toronto, Ontario M5B 1W8, Canada

3. Department of Research, Centre for Development Action, Dhaka-1207, Bangladesh; Department of Monitoring, Evaluation and Learning, Social Development Foundation, Dhaka-1207, Bangladesh

4. Department of Research and Publication, Bangladesh Medical Research Council, Dhaka-1212, Bangladesh

5. Department of Research, Centre for Development Action, Dhaka-1207, Bangladesh; Department of Health, Noora Health, Dhaka-1212, Bangladesh

6. Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Dhaka-1212, Bangladesh

Abstract

Abstract Background Coronavirus disease 2019 (COVID-19) is a global public health concern. Evidence shows that depression and anxiety are common among patients with COVID-19 after recovery. About one-third of the total COVID-19 cases in Bangladesh have been reported in Dhaka city. Therefore, the study aimed to assess the prevalence of depression and anxiety and associated factors among COVID-19 survivors in Dhaka city.Methods A cross-sectional study was conducted among a total of 384 COVID-19 survivors aged 18 years or older. Data collection was done through face-to-face and telephone interviews using a semi-structured questionnaire. Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) scales were used to assess depression and anxiety, respectively. Binary logistic regression analysis was performed to identify factors associated with depression and anxiety.Results The overall prevalence of depression and anxiety was 26.0% and 23.2%, respectively. Respondents aged ≥ 60 years were 2.85 and 3.59 times more likely to have depression and anxiety, respectively than those aged 18–39 years. Hospitalized COVID-19 patients had a 1.98 and 2.28 times higher chance of having depression and anxiety, respectively than non-hospitalized COVID-19 patients. COVID-19 patients with comorbidities were at a 3.48 and 2.87 times higher risk of depression and anxiety, respectively compared to those without comorbidities.Conclusions The study reported a high prevalence of depression and anxiety among COVID-19 survivors in Dhaka city. The findings suggest the need for appropriate interventions to reduce mental health complications in COVID-19 survivors.

Publisher

Research Square Platform LLC

Reference45 articles.

1. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group;Gorbalenya AE;BioRxiv,2020

2. World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic [Internet]. Geneva: WHO. ; 2022 (cited 2022 Jan 10).Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=CjwKCAjw9NeXBhAMEiwAbaY4lj59_CJnyTOLtQa36xQ-zUhxJkUmamWjbE3CEzp9n7I2HjJMGDoCkxoC7QQQAvD_BwE.

3. First coronavirus cases confirmed. The Daily Star [Internet]. 2020 Mar 9 (cited 2022 Jan 10). Available from: https://www.thedailystar.net/frontpage/news/first-coronavirus-cases-confirmed-1878160.

4. World Health Organization (WHO). WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) [Internet]. Geneva: WHO;2020 (cited 2020 Jan 10). Available from: https://cdn.who.int/media/docs/default-source/searo/bangladesh/covid-19-who-bangladesh-situation-reports/who_ban_sitrep_109_20220328.pdf?sfvrsn=b310f5bb_5.

5. Demographia. World urban areas,18th annual edition, 2022. Available from: http://www.demographia.com/db-worldua.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3